SCHEMBL526845

SCHEMBL526845

CCOc1ccnc(I)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.38
MAPK8 P45983 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
HPGD P15428 1/20 0.36
NQO1 P15559 1/20 0.36
BTK Q06187 1/20 0.35
MAPT P10636 1/20 0.34
MAPK1 P28482 3/20 0.34
CYP3A4 P08684 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
RAB9A P51151 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
ADRA2A P08913 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
CHRM1 P11229 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2120022 0.78
SCHEMBL24351052 0.77 NUDT1 (0.39) NUDT1MAPK8SMN1; SMN2HPGDNQO1
SCHEMBL2221308 0.77 KDM4E (0.40) NUDT1MAPK8SMN1; SMN2HPGDNQO1
SCHEMBL3817284 0.77 MAPK8 (0.41) NUDT1MAPK8SMN1; SMN2HPGDNQO1
SCHEMBL11036646 0.75 NUDT1 (0.65) NUDT1SMN1; SMN2MAPTMAPK1NPC1
SCHEMBL12191906 0.72 ALDH1A1 (0.36) NUDT1MAPK8SMN1; SMN2HPGDNQO1
SCHEMBL2410520 0.72 GAA (0.48) NUDT1MAPK8SMN1; SMN2HPGDMAPT
SCHEMBL24714984 0.72 NUDT1 (0.43) NUDT1MAPK8SMN1; SMN2HPGDNQO1
SCHEMBL16511927 0.71 MAPT (0.41) MAPK8NQO1BTKMAPTMAPK1
SCHEMBL15087992 0.71 MAPK8 (0.49) MAPK8SMN1; SMN2NQO1BTKMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598481-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS Bristol-Myers Squibb Company (US) 2013-06-05 EP disclosed
WO-2012015723-A1 SULFONAMIDE COMPOUNDS USEFUL AS CYP17 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-02 WO disclosed